Introduction
The hepatitis B virus (HBV) particle consists of a nucleocapsid core, containing partially single-stranded, circular DNA, coated with an envelope made up of three surface antigens (HBsAg), designated large (p39/gp42), middle (gp33/gp36) and major (p24/gp27) (Heerman et al., 1984) . Studies on the transcription of HBV DNA during the complete replication cycle have demonstrated that three species of cytoplasmic HBV RNA are present in HBV-infected chimpanzee liver tissue and hepatoma cell lines (Cattaneo et al., 1983 (Cattaneo et al., , 1984 Will et al., 1987) . One species, the 3.3 kb RNA [length without the poly(A) tail], is known to encode the HBV core antigen and to serve simultaneously as pregenomic RNA. The other two species of cytoplasmic HBV RNA, which are 2.4 and 2.0 kb in length without the poly(A) tail, are known to encode HBsAgs; the 2.4 kb RNA encodes the large HBsAg, which is translated from the pre-S1 initiation codon, and the 2.0 kb RNA encodes the middle HBsAg, which is translated from the pre-S2 initiation codon, and the major HBsAg, which is translated from the S region initiation codon (TioUais etal., 1985) . Although HBV has a strict host range, replicating only in human and chimpanzee liver cells, HBsAg can be expressed by transfecting cloned HBV DNA into cultured rodent cell lines (Dubois et al., 1980; Christman et al., 1982; Asselsberg et al., t 986; Yoneyama et al., 1988) , in which the 2.0 kb RNA is expressed abundantly (Zelent et al., 1987) . In the past few years several systems for propagating HBV in vitro in human cells have been reported (Sureau et al., 1986; Chang et al., 1987; Tsurimoto et al., 1987; Yaginuma et al., 1987; Sells et aL, 1988; Ochiya et al., 1989) ; in these systems pre-S2 and S RNAs (2.0 kb) are expressed abundantly, and pre-S1 (2.4 kb) RNA is expressed poorly. Suzuki et al. (1989) reported abundant pre-S2 and S RNA (48.8 ~ of the total HBV RNA), and low pre-S1 RNA (7.1~ of the total HBV RNA) expression in human hepatoma cells (HepG2) transiently transfected with cloned HBV DNA.
In this report, in contrast to previous reports, we have shown abundant expression of the 2.4 kb large HBsAg RNA using an adenovirus type 5 (Ad5)-HBV recombinant (Ad5-HBL) bearing 87~ of the HBV genome (Saito et al., 1985) , not only in HepG2 cells, but also in all primate cells tested. In rodent cells, however, expression of the 2-4 kb large HBsAg RNA was poor, as reported previously. Since Ad5-HBL can efficiently infect a broad range of cells, we were able to compare the expression of HBV RNAs and proteins in various cell lines.
Previous reports using plasmid vectors have shown that the secretion of HBsAgs is strongly inhibited when major, middle and large HBsAgs are synthesized together. Using transgenic mice, Chisari et al. (1986) reported that the concentration of HBsAgs in serum decreases as the level of HBsAg expressed in the liver increases; Persing et al. (1986) also reported this using COS7 cells. A subsequent report showed that the pre-S1 region of HBsAg facilitates the retention of HBsAg in the cytoplasm and inhibits the secretion of HBsAg (JingHsiung & Rutter, 1987) . Our results show that the HBsAgs are secreted poorly by primate cells in which expression of the 2.4 kb large HBsAg RNA is abundant, but efficiently by rodent cells in which expression of the 2.4 kb large HBsAg RNA is poor, in agreement with the data obtained using plasmid vectors.
Methods
Cells and viruses. HeLa (human cervical carcinoma), Hul-1 [human foetal liver (Katsuta et al., 1980) ], JHH-4 [HBV genome-negative, human hepatocellular carcinoma (Sujino et al., 1986) ], HepG2 (HBV genome-negative, human hepatocellular carcinoma), KB (human pharyngeal carcinoma), WI-38 (human lung), CV-I (monkey kidney), Vero (monkey kidney), NIH 3T3 (3T3; mouse embryo), L (mouse connective tissue), C 127 (mouse mammary tumour), 3Y-I (rat embryo) and RLC-10 (rat liver) cell lines were used. Cells were grown as monolayers in Eagle's MEM or Dulbecco's modification of Eagle's Ad5 HBL ~ genome Right pre-S1 pre-S2 end medium supplemented with 10 % foetal calf serum. The structure of the genome of recombinant Ad5-HBL is shown in Fig. 1 ; it contains the large Bglll fragment [2-8 kb, nucleotides (nts) 2425 to 1986] of HBV (subtype adr) DNA at a site 0-2 kb downstream from the right terminus of the Ad5 genome (Saito et al., 1986) . Ad5-dlX virus, which does not contain HBV DNA, was used as a control (Saito et al., 1985) . Virus stocks were prepared from the infected KB cell monolayers. Plaque assays were performed on A549 cells (human lung carcinoma).
Reagents. All restriction enzymes were products of Takara Shuzo; S1 nuclease was purchased from Boehringer Mannheim; cytosine fl-D-arabinofuranoside (ara-C) was purchased from Sigma.
Analysis of RNA and DNA. Unless otherwise stated, monolayers were infected with AdS-HBL at a multiplicity of 20 p.f.u./cell and incubated for 2 h at 37 °C in culture medium containing ara-C (75 ~tg/ml). Cytoplasmic RNA was extracted from infected cells by the procedure of Berk et al. (1979) and between 50 and 100 ~tg was hybridized at 51 °C with 25 to 40 ng of specific DN A fragments (Fig. 1 a) . After S 1 nuclease treatment (500 units/ml), DNA-RNA hybrids were fractionated on a gel (Saito et al., 1986 ) and the number of copies of Ad5-HBL DNA per infected cell was determined by dot blot hybridization (Gross-Bellard et al., 1973) using nick-translated HBV DNA as a probe.
Densitometric analysis oJRNA. The quantity of RNA was determined by densitometry using the film scanner of a spectrophotometer (Chromoscan; Joyce Loebl). The linear range of the film density, which is dependent on the concentration of 32p-labelled DNA, was determined using a preflashed film and varying the autoradiographic exposure time. 
51-q
Major HBsAg The numbering system of HBV subtype adr, in which the numbering origin is an EcoRI site, is from Saito et al. (1986) . The S gene probe at the top is the XhoI-BamHI fragment (nts 130 to 1404), labelled by nick translation and used for detection of the SI nuclease-protected DNA shown in Fig. 3 . The 5" XbaI probe is either the SalI XbaI fragment or EcoRl XbaI fragment of pX2S-HBL (Saito et al., 1985) . The 5' ends were labelled by using T4 polynucleotide kinase and used in the SI nuclease mapping shown in medium, and lysed by three cycles of freezing and thawing and sonication. HBsAg in the cell lysate (intracellular HBsAg) and in the culture medium (extracellular HBsAg) was determined using an AUSRIA II RIA diagnostic kit (Abbott Laboratories). Absolute amounts of HBsAg were determined from the standard curve obtained using known amounts of HBsAg purified from human HBV carrier sera.
Immunoprecipitation of HBsAg. Monolayers were infected with Ad5-HBL or Ad5-dlX at a multiplicity of 5 p.f.u./cell. Cell cultures were maintained for 40 min in cysteine-depleted medium and then labelled with 13sS]cysteine (ICN ; > 500 Ci/mmol) between 48 and 72 h post-infection (p.i.). Cell lysates were prepared by the procedure of Goh et al. (1985) and incubated with normal serum and Protein A (Staphylococus aureus Cowan I) for 30 min at 0 °C. After centrifugation, the supernatants were incubated with anti-HBsAg serum for I h at 0 °C and Protein A-bound Igs were eluted in 2.3~ SDS, 5~ 2-mercaptoethanol. The samples were analysed by 12.5~ SDS-PAGE (Heerman et al., 1984) . For immunoprecipitation, either an anti-major HBsAg guinea-pig serum or a mouse monoclonal antibody produced against a synthetic peptide consisting of 13 amino acids from positions 95 to 107 in the pre-S1 region was used (Okamoto et al., 1985) . 
Results

Detection of HBsAg RNAs in a human hepatoma cell line infected with Ad5-HBL
HepG2 cells, differentiated human hepatoma cells, are known to support replication of and virion formation by HBV (Sells et al., 1988) . To examine the expression of HBsAg RNAs in HepG2 cells infected with Ad5-HBL, cytoplasmic RNA was hybridized with the 5' endlabelled Sall-XbaI (nts 2426 to 252) probe (Fig. 1 a) and hybrids protected against S1 nuclease digestion were analysed on a urea-polyacrylamide gel (Fig. 2) . We detected abundant 2-4 kb HBV RNA and less 2-0 kb HBV RNA at both 20 h and 48 h p.i. ; the 2.4 kb R N A was detected as a single 660 nt band, whereas the 2.0 kb RNA was separated into three discrete bands of 280,250 and 245 nts (Fig. 2) because of the heterogeneity of its 5' end, as described previously (Saito et al., 1986; Suzuki et al., 1989) and shown in Fig. 1 (b) . Densitometric analysis showed that the steady-state level of the 2-4 kb RNA was almost 12-fold and eightfold greater than that of the 2.0 kb RNA at 20 h and 48 h p.i., respectively.
Relative abundance of HBsAg RNA
To determine whether the abundance of the 2-4 kb RNA relative to the 2.0 kb RNA was dependent on the origin of the cells (tissue or species), cytoplasmic RNA was prepared 48 h p.i. from various cell lines infected with Ad5-HBL. This RNA was hybridized with an unlabelled 2.8 kb HBV DNA fragment containing the entire HBV DNA fragment contained in Ad5-HBL. After digestion with Sl nuclease, the D N A -R N A hybrids were electrophoresed on a neutral agarose gel, blotted expressed a strikingly large amount of the 2.4 kb RNA (Fig. 3a, lane 3) , whereas another liver cell line, Hul-1 (from human foetal liver), produced a little less 2-4 kb R N A than 2.0 kb R N A (Fig. 3a, lane 2) , similarly to other non-hepatic human cells. In contrast to the different levels of the 2.4 kb RNA in the primate and rodent cells, the steady-state level of the 2.0 kb RNA in the three rodent cell lines, 3T3, L and 3Y1, was comparable with that in human cells [except C127 (lane 10) and RCL-10 (lane 12) in Fig. 3b , where very low-level expression was observed]. The five human cell lines (permissive for Ad5-HBL) and the monkey CV-1 cell line (semi-permissive) contained about 104 DNA copies/ cell (Fig. 3c , lanes 1 to 6), whereas 3T3, L and 3Y-1 rodent cells contained 104 , 103 and 103 copies of Ad5-HBL DNA/cell, respectively (Fig. 3 c, lanes 8, 9 and  11 ). The number of copies of Ad5-HBL DNA was the same in 3T3 mouse cells and CV-1 primate cells, and yet the level of expression of the 2.4 kb RNA differed, so the poor expression of 2.4 kb RNA in rodent cells was probably not due to poor replication of the Ad5-HBL vector, but was species-specific. To compare the ratio of 2.4 kb RNA to 2-0 kb RNA more quantitatively, another S1 nuclease protection experiment was carried out. Cytoplasmic RNA was hybridized with the 5' end-labelled XbaI probe (Fig. 1 a) and S 1-protected hybrids were analysed on a ureapolyacrylamide gel. The 2.4 kb R N A was detected weakly but clearly in rodent cells as a band of 660 nt (Fig.  4, lanes 5 to 7) . Densitometric analysis showed that the steady-state level of 2.4 kb R N A was 50 to 150~o of that of 2-0 kb RNA in all primate cells except JHH-4, in which the level of 2.4 kb RNA was fivefold greater than that of 2.0 kb RNA (Fig. 4, lane 3) . In contrast, in rodent cells the steady-state level of 2.4 kb RNA was only 6~o (3T3) or 12~o (L) of that of the 2-0 kb RNA (Fig. 4, lanes  5 to 7) . Mouse C 127 ceils expressed detectable amounts 
Expression of HBsAg
To determine whether the observed species-specific difference in RNA expression is reflected in its translation into HBsAgs, the time course of HBsAg production and secretion was studied. Eight cell lines were infected with Ad5-HBL and the amount of intracellular HBsAg and extracellular HBsAg was measured at intervals of 24 h (Fig. 5) ; the amounts of HBsAg detected at 72 h p.i. are shown in Table 1 . In all primate cell lines, HBsAg was mainly intracellular (60 to 85 ~o), whereas in rodent cell lines the antigen was found mainly in the culture medium (65 to 79~). The total amount of HBsAg detected differed among the cell lines, being relatively high in the human hepatoma JHH-4 cells, and the mouse 3T3 and L cells (about 500 ng/107 cells at 72 h p.i.). Some rodent cells, RLC-10 (rat liver cell) for example, produced very little HBsAg (Table 1) , probably due to the low number of copies of Ad5-HBL DNA/cell. All human cell lines except JHH-4 produced only a small amount of HBsAg, although 104 copies of Ad5-HBL DNA/cell were present 48 h p.i.
14.3K-- The fact that the distribution of HBsAg was different m primate and rodent cell lines suggested that the HBsAgs expressed in these cells were qualitatively different. To test this possibility, lysates of JHH-4 and 3T3 cells infected with Ad5-HBL were immunoprecipitated with two different anti-HBsAg antibodies (Fig. 6) . We detected six polypeptides of 24K, 27K, 33K, 36K, 39K and 42K in JHH-4 ceils using anti-major HBsAg antibody (Fig. 6a, lane 2) , but using an anti-pre-Sl antibody only a major band of 39K and a faint band of (Feldman & Rapp, 1966) . Cytoplasmic RNA and nuclear DNA were prepared from cells at 20 h p.i. Ara-C treatment reduced the number of copies of Ad5 HBL by 100-fold in both HepG2 and HeLa cells (Fig. 7b, lanes 1 and 2; Fig. 7d,  lanes 1 to 4) . In HepG2 cells, the ratio of 2.4 kb R N A to 2.0 kb RNA, which was 13 in untreated cells, decreased to 7 in ara-C-treated cells (Fig. 7a, lanes 2 and 1) , whereas in HeLa cells the ratio (about 3 in untreated cells) decreased to as low as 0.6 in ara-C-treated cells (Fig. 7c, lanes 1 to 4) , i.e. the expression of 2.4 kb RNA was strongly inhibited by the DNA inhibitor in HeLa cells, whereas the effect was limited in HepG2 cells. Thus, the 2.4 kb RNA was efficiently expressed in differentiated human hepatoma HepG2 cells without extensive virus replication, whereas in non-hepatic HeLa cells the efficient expression of the 2.4 kb R N A required extensive Ad D N A replication.
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42K were detected (Fig. 6b, lane 2) . The cell lysate of Ad5-HBL-infected 3T3 cells contained polypeptides detectable using the anti-pre-S1 antibody (data not shown). Control preparations infected with Ad5-dlX showed several bands of high Mr, but there was no band at the positions equivalent to those of the HBsAg polypeptides ( Fig. 6a and b, lanes 1) . Using the antimajor HBsAg antibody three polypeptides of 24K, 27K and 33K were detected in the 3T3 cells lysate (Fig. 6c,  lane 2) . However, two of these, the 27K and 33K polypeptides, were detected in 3T3 cells infected with Ad5 dlX, so their specificity was not clear. The results showed that human JHH-4 cells express major (24K and 27K), middle (33K and 36K) and large (39K and 42K) HBsAg polypeptides, whereas mouse 3T3 cells express major (and perhaps middle) HBsAg polypeptides but do not express the large HBsAg polypeptide. These results were consistent with the results of the RNA expression experiments described above.
H B V R N A expression with limited A d 5 -H B L D N A replication
The abundant expression of the 2.4 kb R N A in primate ceils was shown to be regulated in a species-specific manner. To study the effect of replication of the Ad
Discussion
We have compared the amounts of HBsAg R N A expressed by an Ad-HBV recombinant in human, monkey and rodent cells. In rodent cells, the major transcripts are the 2.0 kb species, the promoter of which is located within the pre-S gene, in agreement with previous reports (Dubois et al., 1980; Christman et al., 1982; Asselsberg et al., 1986) . In primate cells, in addition to the 2.0 kb RNA, there is abundant expression of the 2.4 kb RNA, the promoter of which precedes the pre-S region. According to the amount of 2.4 kb R N A expressed, cells have been classified into three groups: (l) HepG2 and JHH-4 cells, which express the 2-4 kb RNA more efficiently than the 2.0 kb RNA, (2) Hul-1 and non-hepatic primate cells, which express the same amount of 2.4 kb RNA as 2.0 kb RNA, and (3) rodent cells, which express the 2.4 kb R N A poorly. A similar description of cell specificity was made by Raney et al. (1990) using a chloramphenicol acetyltransferase assay, but the amount of 2-4 kb R N A relative to 2.0 kb RNA appeared to be higher in our system. The cells of groups (1) and (2) secrete the expressed HBsAg poorly, whereas those of group (3) secrete it efficiently (Table 1) . This is consistent with the results of R N A expression experiments, because the large HBsAg, encoded by the 2.4 kb RNA, is known to inhibit the secretion of HBsAg (Chisari et al., 1986; Persing et al., 1986) , and 2.4 kb RNA was abundant in groups (1) and (2). Chang et al. (1989) have reported that the promoter for the large HBsAg is preferentially active in differentiated hepatoma cell lines which express hepatocyte nuclear factor 1 (HNF-1), which regulates the preferential use of the pre-S1 promoter. Our results showing that the HepG2 and JHH-4 cells express abundant 2-4 kb RNA are consistent with the idea that differentiated HepG2 and JHH-4 cells must express HNF-1 abundantly. Hul-1 cells, of human foetal liver origin, may well be less differentiated, thus expressing less HNF-1 and consequently less 2.4 kb RNA.
The experiments with ara-C show that the expression of the 2.4 kb RNA is hardly affected by the DNA inhibitor in differentiated human hepatoma HepG2 cells but is significantly reduced by ara-C in non-hepatic HeLa cells; high level expression of the 2.4 kb RNA in HeLa cells requires Ad DNA replication. This result is consistent with our observation that the expression of HBsAg RNA in HepG2 cells is abundant at an early stage of Ad5-HBL infection, whereas in HeLa cells it is abundant at a later stage (data not shown). It is possible that in HeLa cells expression of the 2.4 kb RNA is regulated in the same way as that of Ad late genes, which begin to be transcribed efficiently after viral DNA replication. The HBsAg RNAs are not transcribed from the Ad late promoter in Ad5-HBL, because the direction of HBV transcription in Ad5-HBL is opposite to that of the Ad late promoter (Saito et al., 1986) . Ad early proteins, such as E 1 A, trans-activate cellular genes in the late stage of infection (Hearing & Shenk, 1983) ; perhaps a factor similar in function to HNF-1 is trans-activated by an Ad protein and regulates the use of the pre-S promoter late in infection. This observation will be useful in the analysis of factors which enhance the expression of the 2-4 kb RNA.
